FDA 483 - Protherics UK Limited - August 13, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Protherics UK Limited, a biological drug substance manufacturer, revealed a significant issue with mold contamination. The firm failed to fully investigate the presence of various molds in a room holding manufacturing materials and stability samples, including inadequate environmental monitoring and a lack of assessment for similar HVAC units. This indicates a potential risk of cross-contamination and raises concerns about the firm's quality event management.
ID · 14850c9b-07c1-4419-b1c9-e62ac966898d